UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

Neoplasma, 2022-12, Vol.69 (6), p.1466-1473

2022

Volltextzugriff (PDF)

Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database

Leukemia & lymphoma, 2017-03, Vol.58 (3), p.601-613

2017

Volltextzugriff (PDF)

Detection of minimal residual disease in mantle cell lymphoma—establishment of novel eight‐color flow cytometry approach

Cytometry. Part B, Clinical cytometry, 2015-03, Vol.88 (2), p.92-100

2015

Volltextzugriff (PDF)

Radiotherapy in early stage follicular lymphoma: is it really the gold standard?

Leukemia & lymphoma, 2015-10, Vol.56 (10), p.2999-3000

Janikova, Andrea

2015

Volltextzugriff (PDF)

Novel Findings in Follicular Lymphoma Pathogenesis and the Concepts of Targeted Therapy

Klinická onkologie, 2017, Vol.30 (4), p.247-257

2017

Volltextzugriff (PDF)

Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study

The Lancet. Haematology, 2015-04, Vol.2 (4), p.e166-e174

2015

Volltextzugriff (PDF)

Vitamin D during cancer treatment

Klinická onkologie, 2015, Vol.28 (2), p.99-104

2015

Volltextzugriff (PDF)

Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)

Klinická onkologie, 2016, Vol.29 (4), p.295-302

2016

Volltextzugriff (PDF)

Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

Annals of hematology, 2023-01, Vol.102 (1), p.107-115

2023

Volltextzugriff (PDF)

LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies

The Journal of molecular diagnostics : JMD, 2021-08, Vol.23 (8), p.959-974

2021

Volltextzugriff (PDF)

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Journal of clinical oncology, 2014-06, Vol.32 (17), p.1782-1791

2014

Volltextzugriff (PDF)

Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.675-684

2019

Volltextzugriff (PDF)

The role of radiotherapy in the treatment of malignant lymphomas - recommendations of the Czech Lymphoma Study Group

Klinická onkologie, 2013, Vol.26 (2), p.99-109

2013

Volltextzugriff (PDF)

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

Leukemia & lymphoma, 2016-12, Vol.57 (12), p.2777-2783

2016

Volltextzugriff (PDF)

The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group

Leukemia research, 2018-10, Vol.73, p.29-38

2018

Volltextzugriff (PDF)

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

Leukemia & lymphoma, 2015-08, Vol.56 (8), p.2350-2356

2015

Volltextzugriff (PDF)

Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.748-755

2019

Volltextzugriff (PDF)

Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

Hematological oncology, 2018-12, Vol.36 (5), p.773-778

2018

Volltextzugriff (PDF)

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database

Leukemia & lymphoma, 2014-04, Vol.55 (4), p.802-810

2014

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaCancer

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Tschechisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Hematology
(23)
Female
(22)
Middle Aged
(21)
Adult
(20)
Aged
(20)
Male
(19)
Oncology
(18)
Treatment Outcome
(14)
Prognosis
(13)
Aged, 80 And Over
(9)
Neoplasm Staging
(9)
Retrospective Studies
(9)
Rituximab
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Lymphoma, Follicular - Drug Therapy
(8)
Lymphoma, Follicular - Pathology
(8)
Czech Republic
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia & Lymphoma
(11)
Klinická Onkologie
(4)
Blood
(3)
Experimental Hematology
(3)
Haematologica
(2)
Annals Of Hematology
(1)
Cancer Medicine
(1)
Clinical Lymphoma & Myeloma
(1)
Cytometry. Part B, Clinical Cytometry
(1)
Hematological Oncology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma

Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration

Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database

Detection of minimal residual disease in mantle cell lymphoma—establishment of novel eight‐color flow cytometry approach

Radiotherapy in early stage follicular lymphoma: is it really the gold standard?

Novel Findings in Follicular Lymphoma Pathogenesis and the Concepts of Targeted Therapy

Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study

Vitamin D during cancer treatment

Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors

Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

The role of radiotherapy in the treatment of malignant lymphomas - recommendations of the Czech Lymphoma Study Group

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry

Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database

Aktive Filter

Suchergebnisse filtern